IP Library Granted Patent US 8,022,037
Granted Patent B2
US 8,022,037 · App. 12/522,446 · Granted Sep 20, 2011

Skin wound healing compositions and methods of use thereof

Assignee: University of Southern California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,022,037
App. No.
12/522,446
Granted
Sep 20, 2011
Kind
B2
Abstract

A wound healing composition comprising an amount of heat shock protein effective to promote wound healing and a method thereof to apply the composition. A preferred heat shock protein is either full-length hsp90α or the middle domain plus the charged sequence of hsp90α. The composition is topically applied to skin wounds, covering the outer surface of the wound. The heat shock protein acts by promoting migration of both human epidermal keratinocyte and dermal fibroblasts to the wound in order to close, heal, and remodel the wound.

Claims (8)

1. A wound healing composition comprising:

an isolated polypeptide fragment comprising the middle domain and the charged sequence of hsp90α, wherein the isolated polypeptide fragment does not comprise the N-terminal ATP-binding domain or the C-terminal C′ domains of hsp90α, in a therapeutically effective amount to promote wound healing in a patient in need thereof; and

a pharmaceutical medium to carry the polypeptide fragment.

2. The wound healing composition according to claim 1 , wherein the amount of polypeptide fragment is from about 0.1 μg/μl to about 100 μg/μl in said pharmaceutical medium.

3. The wound healing composition according to claim 1 , wherein the amount of polypeptide fragment is from about 0.3 μg/μl to about 50 μg/μl in said pharmaceutical medium.

4. The wound healing composition according to claim 1 , wherein the polypeptide fragment contains 394 amino acid units.

5. The wound healing composition according to claim 1 , wherein the polypeptide fragment is from about 38 Kdaltons to about 54 Kdaltons.

6. The wound healing composition according to claim 1 , wherein the pharmaceutical medium is at least one selected from the group consisting of: an aqueous solution, suspension, dispersion, salve, ointment, gel, cream, lotion, spray or paste.

Assignments (2)
CONFIRMATORY LICENSE Recorded Sep 21, 2009
From: UNIVERSITY OF SOUTHERN CALIFORNIA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023257/0561 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2009
From: LI, WEI; CHEN, MEI; WOODLEY, DAVID T.
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 022927/0588 →
Continuity (2)
Provisional Application 60879150 · Jan 8, 2007
Related Publication 20100035815A1 · Feb 11, 2010